Clinical Trials in Seattle

Showing 2781-2800 of 4,491 trials

Evaluating Progression of and Diagnostic Tools for Primary Ciliary Dyskinesia in Children and Adolescents

NCT00450918

Mucociliary clearance, in which mucus secretions are cleared from the breathing airways, is the primary defense mechanism for the lungs. Inhaled particles, including microbes that can cause infections, are normally entrapped in mucus on the airway surfaces and then cleared out by the coordinated action of tiny hair-like structures called cilia. Individuals with primary ciliary dyskinesia (PCD) have defective mucociliary clearance, which in turn leads to lung infections and disease. The purpose of this study is to determine how lung disease progresses over time in children and adolescents with PCD.

Primary Ciliary Dyskinesia

University of North Carolina, Chapel Hill150 participantsStarted Aug 2006

Denver, Colorado, United States • St Louis, Missouri, United States • Chapel Hill, North Carolina, United States +2 more locations

COMPLETEDPhase 2< 1 mile

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

NCT01683409

This is a dose ranging study to evaluate the safety and efficacy of baricitinib in the treatment of participants with mild to moderate diabetic kidney disease.

Diabetic Kidney Disease

Eli Lilly and Company130 participantsStarted Aug 2012

Lancaster, California, United States • San Diego, California, United States • Torrance, California, United States +42 more locations

Evaluating Progression of and Diagnostic Tools for Primary Ciliary Dyskinesia in Children and Adolescents

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

Find Trials by Condition in Seattle

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Pocket Phantom Tool in Improving Accuracy of Quantitative PET/CT Imaging of Patients With Solid Tumors

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma

A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Retrospective Review of Saphenous Vein Incompetence: Venaseal Versus Endovenous Thermal Ablation

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

The Prone Breast Radiation Therapy Trial

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

Firmagon (Degarelix) Intermittent Therapy

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

MRI to Detect Breast Tumors in Women